Migraine

Meta-Analysis: Botulinum A Tops Placebo for Chronic Migraine

Meta-Analysis: Botulinum A Tops Placebo for Chronic Migraine

For chronic migraine, botulinum type A injections are superior to placebo after three months of therapy.

Serum Vitamin D Levels and Risk for Migraine

Serum Vitamin D Levels and Risk for Migraine

Higher levels of serum 25-hydroxyvitamin D may be associated with lower risk for migraine headaches.

Researchers Identify Common Neurologic Manifestations in Fibromuscular Dysplasia

Researchers Identify Common Neurologic Manifestations in Fibromuscular Dysplasia

By

Common and rare neurologic manifestations associated with fibromuscular dysplasia include migraine-type headaches, tinnitus, ischemic stroke, and transient ischemic attack.

Hemicrania Continua: Diagnosis and Treatment

Hemicrania Continua: Diagnosis and Treatment

By

Hemicrania continua, one of the trigeminal primary headaches, causes intense unilateral pain for ≥3 months.

Pseudotumor Cerebri Syndrome Headache Is Often Episodic With Neck, Shoulder Pain

Pseudotumor Cerebri Syndrome Headache Is Often Episodic With Neck, Shoulder Pain

By

A review of patients' medical charts was performed to determine characteristics of headache in pseudotumor cerebri syndrome in adolescents.

Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine

Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine

By

Researchers and pain experts formulated guidelines for the use of onabotulinumtoxinA for the management of chronic migraine.

Ajovy Injection Approved for Migraine Prevention in Adults

Ajovy Injection Approved for Migraine Prevention in Adults

By

The primary efficacy endpoint was the mean change from baseline in the monthly average number of headache days of at least moderate severity during the 3-month treatment period.

Fremanezumab May Be Efficacious for Comorbid Chronic Migraine and Depression

Fremanezumab May Be Efficacious for Comorbid Chronic Migraine and Depression

By

Fremanezumab may be efficacious for the prophylaxis of chronic migraine in individuals with comorbid migraine and moderate/moderate to severe depression.

Lower Dose DFN-11 for Episodic Migraine Associated With Fewer Side Effects

Lower Dose DFN-11 for Episodic Migraine Associated With Fewer Side Effects

By

DFN-11, a 3 mg subcutaneous sumatriptan autoinjector, may provide an alternative to SC sumatriptan 6 mg for individuals with episodic migraine.

New Device Available for Patients With Episodic Cluster Headache, Migraine

New Device Available for Patients With Episodic Cluster Headache, Migraine

By

GammaCore Sapphire, a new non-invasive hand-held device for migraine and episodic cluster headache treatment, has been made available by electroCore.

Chronic Migraine and Medication Overuse Headache Linked to Stress

Chronic Migraine and Medication Overuse Headache Linked to Stress

By

The investigators sought to evaluate whether early-life traumatic experiences, stressful life events, and alexithymia are associated with chronic migraine and medication overuse headache.

Galcanezumab Beats Placebo for Episodic Migraine

Galcanezumab Beats Placebo for Episodic Migraine

For patients with episodic migraine, galcanezumab is better than placebo for reducing migraine headache days.

Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine

Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine

By

Individuals with chronic vs episodic migraine may be more likely to experience chronic back pain, chronic pain, neck pain, anxiety, and depression.

Comorbidity More Likely With Chronic Migraine vs Episodic Migraine

Comorbidity More Likely With Chronic Migraine vs Episodic Migraine

By

Researchers deployed a survey to determine the extent of pain, psychiatric, endocrine, and neurologic comorbidities in patients with chronic or episodic migraine.

Erenumab for Episodic Migraine: A Closer Look at the Data

Erenumab for Episodic Migraine: A Closer Look at the Data

By

For individuals with migraine frequency of 4 to 14 episodes per month, prophylactic medications and analgesics are required.

Early Treatment, Milder Migraine Symptoms Linked to Improved Outcomes With OnabotulinumtoxinA

Early Treatment, Milder Migraine Symptoms Linked to Improved Outcomes With OnabotulinumtoxinA

By

For patients with chronic migraine, onabotulinumtoxinA was shown to have a better outcome.

Erenumab, Fremanezumab Reduce Migraine Frequency, Burden

Erenumab, Fremanezumab Reduce Migraine Frequency, Burden

By

Both erenumab and fremanezumab are currently under review by the FDA for the treatment of migraine.

Episodic Migraine Increases Risk for CVD, Subsequent Contraindications to Therapy

Episodic Migraine Increases Risk for CVD, Subsequent Contraindications to Therapy

By

Clinicians need to consider treatments for episodic migraine that may be contraindicated if a patient also has cardiovascular disease.

Using Perceived Stress to Predict Episodic Migraine Attacks

Using Perceived Stress to Predict Episodic Migraine Attacks

By

Future predictive models may need to include other migraine risk factors to enhance predictive accuracy.

Benefits of Adjunctive Acupressure for Chronic Migraine Examined

Benefits of Adjunctive Acupressure for Chronic Migraine Examined

By

Acupressure is not a beneficial adjunctive therapy to sodium valproate for the treatment of chronic migraine with aura.

Targeted, Reduced Number of OnabotulinumtoxinA Injections Effective for Chronic Migraine

Targeted, Reduced Number of OnabotulinumtoxinA Injections Effective for Chronic Migraine

By

More targeted injection sites may improve efficacy and the overall patient experience in chronic migraine.

Identifying Early Triggers, Symptoms of Vestibular Migraine

Identifying Early Triggers, Symptoms of Vestibular Migraine

By

Vestibular migraine often goes unrecognized particularly in the absence of headache.

High Compliance, Satisfaction With OnabotulinumtoxinA for Migraine

High Compliance, Satisfaction With OnabotulinumtoxinA for Migraine

By

The majority of centers follow protocols for administration of onabotulinumtoxinA.

Vestibular Rehabilitation Effective Treatment for Vestibular Migraine

Vestibular Rehabilitation Effective Treatment for Vestibular Migraine

By

Headache, dizziness, and psychological factors in patients with vestibular migraine were alleviated by vestibular rehabilitation.

Symptomatic Connection Between Chronic Migraine, Temporomandibular Disorder

Symptomatic Connection Between Chronic Migraine, Temporomandibular Disorder

By

A growing body of research indicates a number of shared features between chronic migraine and temporomandibular disorders.

Chronic Migraine and Medication Overuse: Relapse Outcomes

Chronic Migraine and Medication Overuse: Relapse Outcomes

By

In chronic migraine and medication overuse, those who frequently relapse into overuse after withdrawal have a worse clinical and psychological profile than patients who relapse less frequently.

Hypothalamus May Play a Central Role in Chronic Migraine

Hypothalamus May Play a Central Role in Chronic Migraine

By

During headache, patients with chronic migraine had greater activity in the right anterior hypothalamic region than patients with episodic or no migraine.

Monthly Migraine Days Reduced With CGRP Antagonist Erenumab

Monthly Migraine Days Reduced With CGRP Antagonist Erenumab

By

Treatment with the monoclonal antibody erenumab reduced the number of monthly migraine days experienced in patients with episodic migraine.

History of Migraine Yields Higher Risk for Hypertension in Women

History of Migraine Yields Higher Risk for Hypertension in Women

By

Women with a history of migraine are at increased risk for developing hypertension.

Psychological Factors May Be Treatment Target in Chronic Migraine

Psychological Factors May Be Treatment Target in Chronic Migraine

By

The study found a strong link between chronic migraine and psychological symptoms and beliefs that contribute to disability.

Sign Up for Free e-newsletters



CME Focus